Kasvutx
2 known investors
Kasvu is a drug-discovery company developing small-molecule neuroplastogens — selective positive allosteric modulators of the TrkB receptor — using an AI-powered 3D model of the receptor and structure-based drug design. Its molecules aim to improve neuronal plasticity and cognitive function as treatments for neuropsychiatric conditions and neurodegenerative diseases such as Alzheimer's and Parkinson's.
AI & Machine LearningBiotechMental Health
Founders & leadership
JM
Jami MandelinCEO
RM
Rafael MolinerCo-Founder & Principal Scientist